- Home
- HALO vs BETA Comparison
HALO vs BETA Comparison
Compare HALO & BETA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- BETA
- Stock Information
- Founded
- HALO 1998
- BETA 2017
- Country
- HALO United States
- BETA United States
- Employees
- HALO N/A
- BETA N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- BETA Aerospace
- Sector
- HALO Health Care
- BETA Industrials
- Exchange
- HALO Nasdaq
- BETA Nasdaq
- Market Cap
- HALO 7.6B
- BETA 7.0B
- IPO Year
- HALO N/A
- BETA 2025
- Fundamental
- Price
- HALO $73.13
- BETA $26.64
- Analyst Decision
- HALO Buy
- BETA
- Analyst Count
- HALO 12
- BETA 0
- Target Price
- HALO $73.33
- BETA N/A
- AVG Volume (30 Days)
- HALO 2.7M
- BETA 2.4M
- Earning Date
- HALO 11-03-2025
- BETA 12-04-2025
- Dividend Yield
- HALO N/A
- BETA N/A
- EPS Growth
- HALO 56.68
- BETA N/A
- EPS
- HALO 4.74
- BETA N/A
- Revenue
- HALO $1,242,852,000.00
- BETA $23,068,000.00
- Revenue This Year
- HALO $32.47
- BETA N/A
- Revenue Next Year
- HALO $24.31
- BETA N/A
- P/E Ratio
- HALO $15.34
- BETA N/A
- Revenue Growth
- HALO 31.19
- BETA N/A
- 52 Week Low
- HALO $46.26
- BETA $22.40
- 52 Week High
- HALO $79.50
- BETA $39.50
- Technical
- Relative Strength Index (RSI)
- HALO 63.53
- BETA N/A
- Support Level
- HALO $68.09
- BETA N/A
- Resistance Level
- HALO $70.81
- BETA N/A
- Average True Range (ATR)
- HALO 2.26
- BETA 0.00
- MACD
- HALO 0.46
- BETA 0.00
- Stochastic Oscillator
- HALO 80.82
- BETA 0.00
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.